Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management
Nikhil Gupta, Raghav Yelamanchi
World Journal of Gastroenterology (2021) Vol. 27, Iss. 23, pp. 3158-3181
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis
Irena Ilić, Milena Ilić
World Journal of Gastroenterology (2022) Vol. 28, Iss. 32, pp. 4698-4715
Open Access | Times Cited: 80
Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3.
Oscar Fraile‐Martínez, Cielo García‐Montero, Leonel Pekarek, et al.
PubMed (2024) Vol. 39, Iss. 1, pp. 35-40
Closed Access | Times Cited: 11
Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Pancreatic cancer, radiomics and artificial intelligence
Luis Martı́-Bonmatı́, Leonor Cerdá-Alberich, Alexandre Pérez‐Girbés, et al.
British Journal of Radiology (2022) Vol. 95, Iss. 1137
Open Access | Times Cited: 28
Diagnostic Accuracy of Radiomics in the Early Detection of Pancreatic Cancer: A Systematic Review and Qualitative Assessment Using the Methodological Radiomics Score (METRICS)
María Estefanía Renjifo-Correa, Salvatore Claudio Fanni, Luis Alfonso Bustamante Cristancho, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 803-803
Open Access
The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer
Ali Zakaria, Bayan Al-Share, Jason Klapman, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 21
Importance of Anatomical Variation of the Hepatic Artery for Complicated Liver and Pancreatic Surgeries: A Review Emphasizing Origin and Branching
Kapil Malviya, Ashish Verma
Diagnostics (2023) Vol. 13, Iss. 7, pp. 1233-1233
Open Access | Times Cited: 12
Hydrogel PCDME creates pancreatic cancer stem cells in OXPHOS metabolic state with TXNIP elevation
Yuma Aoki, Lei Wang, Masumi Tsuda, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151416-151416
Closed Access
Exploring the prognostic role of cluster of differentiation 47 in patients with advanced pancreatic cancer: a comparative cohort study
Eden Demere Amare, S.-H. Lee, Dongho Choi, et al.
Annals of Surgical Treatment and Research (2025) Vol. 108, Iss. 2, pp. 98-98
Open Access
MYH knockdown in pancreatic cancer cells creates an exploitable DNA repair vulnerability
James Ephraums, Janet Youkhana, Aparna Raina, et al.
Neoplasia (2025) Vol. 61, pp. 101138-101138
Open Access
Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A
Jingya Wang, Zhirui Zeng, Shan Lei, et al.
Journal of Cancer (2022) Vol. 13, Iss. 4, pp. 1229-1240
Open Access | Times Cited: 16
Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD)
Yuhan Yang, Lei Cao, Zengya Guo, et al.
Experimental Cell Research (2022) Vol. 421, Iss. 2, pp. 113402-113402
Closed Access | Times Cited: 16
Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway
Mengyang Ding, Jingyu Liu, Honghui Lv, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial
Qin Wang, Fan Tong, Qiao Li, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 3
Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials
Shaoming Song, Haojie Jin, Qinghao Cheng, et al.
Surgical Endoscopy (2022) Vol. 36, Iss. 8, pp. 5559-5570
Closed Access | Times Cited: 15
Proteomics-Driven Biomarkers in Pancreatic Cancer
Luís Ramalhete, Emanuel Vigia, Rúben Araújo, et al.
Proteomes (2023) Vol. 11, Iss. 3, pp. 24-24
Open Access | Times Cited: 8
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 8, pp. 1456-1468
Open Access | Times Cited: 12
Surgical treatment of pancreatic cancer: Currently debated topics on morbidity, mortality, and lymphadenectomy
Sergio Pedrazzoli
Surgical Oncology (2022) Vol. 45, pp. 101858-101858
Closed Access | Times Cited: 11
Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor
Sergio Pedrazzoli
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6461-6461
Open Access | Times Cited: 6
Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma
Yanyan Kong, Fang Xie, Zhengwei Zhang, et al.
European Radiology (2023) Vol. 33, Iss. 10, pp. 7077-7088
Closed Access | Times Cited: 5
ETS transcription factor ELK3 in human cancers: An emerging therapeutic target
Sulieman Ibraheem Shelash Al-Hawary, Harikumar Pallathadka, Ahmed Hjazi, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154728-154728
Closed Access | Times Cited: 4
Engineering of a Fully Human Anti-MUC-16 Antibody and Evaluation as a PET Imaging Agent
Hanan Babeker, Jessica Pougoue Ketchemen, Arunkumar Annan Sudarsan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2824-2824
Open Access | Times Cited: 7
Comparison of clinical outcomes and prognosis between total pancreatectomy and pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis
Shengqian Hong, Jiao Ren, Sufang Zhang, et al.
ANZ Journal of Surgery (2023) Vol. 93, Iss. 12, pp. 2820-2827
Open Access | Times Cited: 3
Diabetes Mellitus and Pancreatic Cancer: Investigation of Causal Pathways Through Mendelian Randomization Analysis
Zuliang Deng, Wenxing Long, Han-ping Duan, et al.
BIO Integration (2023) Vol. 4, Iss. 4
Closed Access | Times Cited: 2
Implications of cancer stem cells in diabetes and pancreatic cancer
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Life Sciences (2022) Vol. 312, pp. 121211-121211
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top